CLEC7A and neoplasm: These would not only (over)activate the CLEC7A pathway but also specific, TLR cascades upregulated in the non-responder tumor.33, 34, 35 This immune-stimulatory strategy could also benefit from the knowledge of the mutated proteins in the tumor.